Crystal Structure of the Catalytic Domain of the Human Cell Cycle Control Phosphatase, Cdc25A

Cdc25 phosphatases activate the cell division kinases throughout the cell cycle. The 2.3 A structure of the human Cdc25A catalytic domain reveals a small alpha/beta domain with a fold unlike previously described phosphatase structures but identical to rhodanese, a sulfur-transfer protein. Only the active-site loop, containing the Cys-(X)5-Arg motif, shows similarity to the tyrosine phosphatases. In some crystals, the catalytic Cys-430 forms a disulfide bond with the invariant Cys-384, suggesting that Cdc25 may be self-inhibited during oxidative stress. Asp-383, previously proposed to be the general acid, instead serves a structural role, forming a conserved buried salt-bridge. We propose that Glu-431 may act as a general acid. Structure-based alignments suggest that the noncatalytic domain of the MAP kinase phosphatases will share this topology, as will ACR2, a eukaryotic arsenical resistance protein.

[1]  G. Ramponi,et al.  Structure and function of the low Mr phosphotyrosine protein phosphatases. , 1997, Biochimica et biophysica acta.

[2]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[3]  C. Stauffacher,et al.  Crystal structure of bovine heart phosphotyrosyl phosphatase at 2.2-A resolution. , 1994, Biochemistry.

[4]  E. Fauman,et al.  Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate , 1994, Nature.

[5]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[6]  P. Nordlund,et al.  The crystal structure of a low-molecular-weight phosphotyrosine protein phosphatase , 1994, Nature.

[7]  A. Goffeau,et al.  Isolation of Three Contiguous Genes, ACR1, ACR2 and ACR3, Involved in Resistance to Arsenic Compounds in the Yeast Saccharomyces cerevisiae , 1997, Yeast.

[8]  Laurent Meijer,et al.  Sequential Dephosphorylation of p34cdc2 on Thr-14 and Tyr-15 at the Prophase/Metaphase Transition* , 1996, The Journal of Biological Chemistry.

[9]  J. Noel,et al.  Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization , 1996, Nature.

[10]  Jack E. Dixon,et al.  Crystal Structure of the Dual Specificity Protein Phosphatase VHR , 1996, Science.

[11]  J. Dixon,et al.  A catalytic mechanism for the dual-specific phosphatases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Wysocki,et al.  The Saccharomyces cerevisiae ACR3 Gene Encodes a Putative Membrane Protein Involved in Arsenite Transport* , 1997, The Journal of Biological Chemistry.

[13]  D. Barford,et al.  Crystal structure of human protein tyrosine phosphatase 1B. , 1994, Science.

[14]  A. Yamauchi,et al.  Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. , 1997, Blood.

[15]  Kathleen L. Gould,et al.  Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis , 1989, Nature.

[16]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[17]  P. Beer-Romero,et al.  Identification of an essential acidic residue in Cdc25 protein phosphatase and a general three‐dimensional model for a core region in protein phosphatases , 1996, Protein science : a publication of the Protein Society.

[18]  H. Kowarzyk.  Structure and Function. , 1910, Nature.

[19]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[20]  A. Kumagai,et al.  The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system , 1991, Cell.

[21]  B. Rost,et al.  Combining evolutionary information and neural networks to predict protein secondary structure , 1994, Proteins.

[22]  Xu Xu,et al.  Roles of Active Site Residues and the NH-terminal Domain in the Catalysis and Substrate Binding of Human Cdc25 (*) , 1996, The Journal of Biological Chemistry.

[23]  E. Karsenti,et al.  Phosphorylation and activation of human cdc25‐C by cdc2‐‐cyclin B and its involvement in the self‐amplification of MPF at mitosis. , 1993, The EMBO journal.

[24]  S. French,et al.  On the treatment of negative intensity observations , 1978 .

[25]  S. Keyse,et al.  Amino acid sequence similarity between CL100, a dual-specificity MAP kinase phosphatase and cdc25. , 1993, TIBS -Trends in Biochemical Sciences. Regular ed.

[26]  E. Nigg,et al.  Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. , 1991, The EMBO journal.

[27]  S. Moreno,et al.  Clues to action of cdc25 protein , 1991, Nature.

[28]  J. Dixon,et al.  Dissecting the catalytic mechanism of protein-tyrosine phosphatases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Beach,et al.  Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins , 1991, Cell.

[30]  J. Dixon,et al.  Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. , 1991, The Journal of biological chemistry.

[31]  J. Dixon,et al.  A Tyr/Ser protein phosphatase encoded by vaccinia virus , 1991, Nature.

[32]  R. Fisher.  CDKs and cyclins in transition(s). , 1997, Current opinion in genetics & development.

[33]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[34]  Marc W. Kirschner,et al.  cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2 , 1991, Cell.

[35]  R. Honda,et al.  Dephosphorylation of human p34 cdc2 kinase on both Thr‐14 and Tyr‐15 by human cdc25B phosphatase , 1993, FEBS letters.

[36]  A. Kumagai,et al.  The cdc25 protein contains an intrinsic phosphatase activity , 1991, Cell.

[37]  A T Brünger,et al.  Slow-cooling protocols for crystallographic refinement by simulated annealing. , 1990, Acta crystallographica. Section A, Foundations of crystallography.

[38]  C. Sander,et al.  The FSSP database of structurally aligned protein fold families. , 1994, Nucleic acids research.

[39]  E. Karsenti,et al.  Activation of the phosphatase activity of human cdc25A by a cdk2‐cyclin E dependent phosphorylation at the G1/S transition. , 1994, The EMBO journal.

[40]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[41]  U. Strausfeld,et al.  Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein , 1991, Nature.

[42]  D. Donoghue,et al.  cdc25+ encodes a protein phosphatase that dephosphorylates p34cdc2. , 1992, Molecular biology of the cell.

[43]  J. Dixon,et al.  Kinetic Analysis of the Catalytic Domain of Human Cdc25B* , 1996, The Journal of Biological Chemistry.

[44]  G. Zanotti,et al.  Active Site Structural Features for Chemically Modified Forms of Rhodanese* , 1995, The Journal of Biological Chemistry.

[45]  W. Hol,et al.  The covalent and tertiary structure of bovine liver rhodanese , 1978, Nature.

[46]  H Nojima,et al.  Cdc25A is a novel phosphatase functioning early in the cell cycle. , 1994, The EMBO journal.

[47]  E. Fauman,et al.  Structure and function of theprotein tyrosine phosphatases , 1996 .

[48]  P. Jeffrey,et al.  Structural basis of cyclin-dependent kinase activation by phosphorylation , 1996, Nature Structural Biology.

[49]  Amos Bairoch,et al.  The PROSITE database, its status in 1997 , 1997, Nucleic Acids Res..

[50]  C. Peng,et al.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. , 1997, Science.